By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Marinus Pharmaceuticals 

21 Business Park Drive

Branford  Connecticut  06405  U.S.A.
Phone: 203-315-0566 Fax: 203-315-0565



Start Up

Company News
Marinus Pharma (MRNS) Release: Ganaxolone and Diazepam Administered Intravenously Synergistically Block Seizures In Animal Model Of Status Epilepticus 11/15/2016 9:26:04 AM
Marinus Pharma (MRNS) Provides Business Update And Reports Third Quarter 2016 Financial Results 11/3/2016 9:07:18 AM
Marinus Pharma (MRNS) Release: Ganaxolone Phase I Data Supports Progressing To Phase II In Patients With Status Epilepticus 10/19/2016 8:10:48 AM
Marinus Pharma (MRNS) Release: Ganaxolone Reduces Seizures In Females With PCDH19 Pediatric Epilepsy 9/29/2016 11:08:10 AM
Marinus Pharma (MRNS) Appoints Seth H.Z. Fischer To Its Board Of Directors 9/7/2016 9:01:49 AM
Marinus Pharma (MRNS)'s Stock Plummets as Seizure Drug Flunks Phase III Study 6/13/2016 6:24:29 AM
Marinus Pharmaceuticals (MRNS) Receives FDA Orphan Drug Designation For Ganaxolone IV To Treat Status Epilepticus 4/15/2016 9:37:44 AM
Marinus Pharmaceuticals (MRNS) Presents Additional Responder Analysis Data For Ganaxolone In Focal Onset Seizures At The American Epilepsy Society Annual Meeting 12/7/2015 12:03:36 PM
Marinus Pharmaceuticals (MRNS) Bolsters Clinical And Regulatory Expertise 12/3/2015 11:20:14 AM
Marinus Pharmaceuticals (MRNS)'s Ganaxolone To Be Featured In Two Poster Presentations At The 69th Annual Meeting Of American Epilepsy Society 11/19/2015 11:07:29 AM